| Literature DB >> 34239926 |
S Storelli1, A Caputo2, G Palandrani1, M Peditto2, M Del Fabbro1, E Romeo1, G Oteri2.
Abstract
OBJECTIVE: The objective of the present review is to assess the implant survival, marginal bone loss, and biomechanical features of narrow-diameter implants (2.5-3.5 mm) supporting or retaining full-arch fixed or removable restorations.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34239926 PMCID: PMC8241526 DOI: 10.1155/2021/5571793
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Reduced-diameter implant classification.
| Category | Diameter |
|---|---|
| 1 | <2.5 (mini-implants) |
| 2 | 2.5 mm to <3.3 mm |
| 3 | 3 mm to 3.5 mm |
Figure 1Search strategy used and hits for each searched database.
| Database of published studies | Search strategy used | Hits |
|---|---|---|
| MEDLINE searched via PubMed searched on March 24, 2019 | (edentulous) AND ((((((((small diameter implant) OR small-diameter implant) OR narrow implant) OR mini-implant) OR mini implant) OR transitional implant) OR temporary implant) OR provisional implant) | 830 |
| Cochrane Central Register of Controlled Trials searched on March 20, 2019 | (edentulous) AND (small diameter implant OR small-diameter implant OR narrow implant OR mini-implant OR mini implant OR transitional implant OR temporary implant OR provisional implant) | 178 |
| Google Scholar searched on March 23, 2019, via | (“edentulous”) AND (“small diameter implant” OR small-diameter implant OR narrow implant OR mini-implant OR “mini implant” OR transitional implant OR temporary implant OR provisional implant) | 1230 |
| TOT 2238 |
Excluded papers with reasons.
| Reason of exclusion | Number of excluded studies |
|---|---|
| Mean follow‐up < 6 months | 6 |
| Mixed diameter | 55 |
| Partially edentulous | 21 |
| Out of topic (diameter > 3.5 mm or <2.5 mm) | 183 |
| Bone regeneration | 11 |
| Same pool of patients of another article | 3 |
| Number of patients < 10 | 1 |
| Nonhuman study | 9 |
| Review | 1 |
| Language | 4 |
Risk of bias.
| Author | Design | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias |
|---|---|---|---|---|---|---|---|---|
| Abbas H. et al. | Prospective |
|
|
|
|
|
|
|
| Aunmeungtong W. et al. | Prospective RCT |
|
|
|
|
|
|
|
| El-Sheikh AM et al. | Prospective |
|
|
|
|
|
|
|
| Jawad S. et al. | Prospective RCT |
|
|
|
|
|
|
|
| Ma et al. a-b | Prospective RCT |
|
|
|
|
|
|
|
| Marcello-Machado et al. | Prospective |
|
|
|
|
|
|
|
| Morneburg | Retrospective |
|
|
|
|
|
|
|
| Müller F. et al. | Prospective RCT |
|
|
|
|
|
|
|
| Zweers et al. | Retrospective |
|
|
|
|
|
|
|
Estimated implant survival rate and MBL at 5 years for the included studies.
| Author | Implant survival rate reported | Estimated survival rate at 5 years (%) | MBL reported | Estimated mean MBL at 5 years | Prosthesis survival rate |
|---|---|---|---|---|---|
| Abbas H. et al. | 95.8% | 94.8% | 1.25 mm | 1.56 mm | NR |
| Aunmeungtong W. et al. | 100% | 100% | 0.56 mm | 2.82 mm | NR |
| El-Sheikh AM et al. | 100% | 100% | 0.8 mm | 2 mm | 100% |
| Jawad S. et al. | 100% | 100% | NR | NR | 100% |
| Ma et al. | 84.7% | 89.88% | 2.45 mm | 1.61 mm | NR |
| Marcello-Machado et al. | 83.3% | 81.7% | 0 mm | 0 mm | Nr |
| Morneburg | 95.5% | 96.27% | 1.1 mm | 0.92 mm | NR |
| Müller F. et al. | 98.35% | 98.35% | 0.6 mm | 0.6 mm | NR |
| Zweers et al. | 100% | 100% | 0.48 mm | 0.8 mm | 100% |
| Estimated cumulative survival rate at 5 years (%) | Estimated cumulative MBL at 5 years (%) |
Life table analysis.
| Interval (months) | Implants at risk | Failed implants | Dropouts/lost to follow-up | Implant survival rate | Cumulative survival rate |
|---|---|---|---|---|---|
| 0–6 | 885 | 17 | 19 | 98.08% | 98.08% |
| 6–12 | 849 | 3 | 182 | 99.65% | 97.73% |
| 12–24 | 664 | 1 | 140 | 99.85% | 97.59% |
| 24–36 | 523 | 0 | 156 | 100.00% | 97.59% |
| 36–48 | 367 | 1 | 87 | 99.73% | 97.32% |
| 48–60 | 279 | 1 | 99 | 99.64% | 96.97% |
| 60–72 | 179 | 1 | 10– | 99.44% | 96.43% |
| 72–84 | 168 | 1 | 0 | 99.40% | 95.85% |
| 84–96 | 167 | 0 | 6 | 100.00% | 95.85% |
| 96–108 | 161 | 0 | 125 | 100.00% | 95.85% |
| 108–120 | 36 | 0 | 36 | 100.00% | 95.85% |
Figure 2Kaplan-Meier analysis divided by implant diameter range.
| Author | Year | Study type | Study type 2 | Follow-up mean (range) | Surgical intervention (surgical guide) | Implant system | Implant type | Abutments |
|---|---|---|---|---|---|---|---|---|
| Abbas H. et al. | 2017 | Prospective | Case series | 4 years (nr) | Flapless (nr) | Implasa Höchests | Two pieces | Ball attachments |
| Aunmeungtong W. et al. | 2016 | Prospective | rct | 1 year (nr) | Flapless (lab template) | pw plus | Two pieces | Equator |
| El-Sheikh AM et al. | 2012 | Prospective | Case series | 2 years (nr) | Flap (nr) | Straumann | Two pieces | Locator abutment |
| Jawad S. et al. | 2017 | Prospective | rct | 6 months (nr) | Flap (nr) | Astra | Two pieces | Ball attachments |
| Ma et al. | 2016 | Prospective | rct | 7.6 years (1-10 years) | Flap (nr) | Nobel/southern | Two pieces | Ball attachments/u shape bar |
| Marcello-Machado et al. | 2018 | Prospective | Cohort | 1 year (1 year) | Flap (nr) | Neodent | Two pieces | Equator |
| Morneburg | 2008 | Prospective | Cohort | 6 years (1-9 years) | Flapless (lab template) | Microplant, Komet Brasseler Group | Two pieces | Magnetic/o-ring |
| Müller F. et al. | 2015 | Prospective | rct | 5 years (3-6 years) | nr | Straumann | Two pieces | Locator abutment |
| Zweers et al. | 2013 | Retrospective | Cohort | 3 years (nr) | Flap (lab template) | Straumann | Two pieces | Ball/locator |
| Patient age—mean (restored arch) | Initial | Initial | Initial | Implant diameter (implant length) | Loading | Prosthesis type |
|---|---|---|---|---|---|---|
| 53.5 (mandible) | 12 (12) | 12 (12) | 24 (24) | 3.2 mm (11.5 mm) | Immediate | 12 ovd on 2 implants |
| 67.92 (mandible) | 40 (40) | 40 (40) | 120 (120) | 3 mm (12 mm) | Immediate | 20 ovd on 2 implants; 20 ov on 4 implants |
| 60.4 (mandible) | 20 (20) | 20 (20) | 50 (50) | 3.3 mm (10/12/14 mm) | Early | 10 ovd on 2 implants/10 ov on 3 implants |
| 68.5 (mandible) | 24 (22) | 24 (24) | 48 (44) | 3 mm (11 mm) | Early | ovd su 2 implants |
| 64 (maxilla and mandible) | 39 (23) | 39 (23) | 117 (69) | 3.3 mm/3.25 mm (10/11.5/13/15 mm) | Conventional | ovd on 2 implants (mandible); old on 3 implants with bar or ball att. (maxilla) |
| 67.5 (mandible) | 30 (30) | 30 (20) | 60 (50) | 2.9 mm (10 mm) | 3 months | ovd on 2 implants |
| 69 (mandible) | 67 (61) | 67 (61) | 134 (122) | 2.5 mm (09/12/15 mm) | Conventional | ovd on 2 implants |
| 72 ± 8 (mandible) | 91 (47) | 91 (47) | 182 (94) | 3.3 mm (8/10/12/14 mm) | Early | ovd on 2 implants |
| 69 (mandible) | 75 (75) | 75 (75) | 150 (150) | 3.3 mm (8/10/12/14 mm) | Early | ovd on 2 implants |